Editorial Board ::: Current Pharmaceutical Design

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)

Volume 23, 46 Issues, 2017

Download PDF Flyer

Current Pharmaceutical Design

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

William A. Banks
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.611
5 - Year: 3

Editorial Board


William A. Banks (Biography
William A. Banks

Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.


Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108

Regional Editors:

Region: Asia
Seiji Shioda (Biography
Seiji Shioda

Dr. Seiji Shioda obtained a doctorate (Ph.D) in Medical Science in Showa University School of Medicine, Tokyo. Currently Dr. Shioda is professor of Hoshi University, Global Research Center for Innovative Science (GRIL), Peptides Drug Innovation. Dr. Shioda is also an Adjunct Professor of Tulane University Medical School. He has published more than 500 scientific publications and is a named inventor of 10 issued Japanese patents. Dr. Shioda has been the Regional Editor (Asia) of Current Pharmaceutical Design, published by Bentham Science Publishers.


Hoshi University
Region: Europe
Dimitri Mikhailidis (Biography
Dimitri Mikhailidis

Dimitri Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor, Univ. of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis.

He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,118 citations on the ISI index, Core Collection (H-factor 64).


Royal Free Hospital

Section Editors:

Mingyuan Gao (Biography
Mingyuan Gao

Dr. Gao graduated from Jilin University (BSc, MSc, Ph.D). He worked as a postdoc at Max-Planck Institute of Colloids and Interfaces from 1996-1998. He then was employed as a group leader from 1998 to 2001 by University of Munich. Dr. Gao took his current position upon a "Hundred-talent Program" of CAS in 2001. He received the “National Science Fund for Distinguished Young Scholars” from NSFC in 2002. With a cumulative IF points of 1000+, he has published 140 peer-reviewed articles and holds 16 patents. Dr. Gao is currently a full professor in Institute of Chemistry, Chinese Academy of Sciences. He is also a Chair Professor and Director of a Center for Molecular Imaging and Nuclear Medicine at Soochow University.


The Chinese Academy of Sciences

(Immune Agents)
Emilio Jirillo (Biography
Emilio Jirillo

Emilio Jirillo is full professor of Immunology at University of Bari Medical School (Bari, Italy) since 1986.His current fields of interest are: mucosal immunity, microbial immunity and immunonutrition.Especially in this last field, he has recently published in vitro and in vivo studies on the anti inflammatory effects of polyphenols . He is author of more than 560 papers(326 scientific papers are listed in PUBMED), even including books and chapters of books. He is editor-in-chief- of the following Bentham journals:1. Endocrine Metabolic Immune Disorders-Drug Targets ; 2.Clinical Immunology Endocrine Metabolic Drugs.


Bari University

(Endocrine and Metabolic Agents)
Abba Kastin (Biography
Abba Kastin

Abba J. Kastin was born in Ohio and educated at Harvard College and Harvard Medical School. After starting his work on neuropeptides as a Clinical Associate at NIH, he went to Louisiana where he now holds an endowed chair at the Pennington Biomedical Research Center. In recognition of the concepts he introduced into the field of biologically active peptides, Dr. Kastin has been made an honorary member of 9 foreign medical societies, has received 2 honorary professorships and 3 honorary doctorates (the last one from Uppsala University), and has won several national and international awards. Author of more than 900 papers cited more than 34,500 times (H index 87), he has been listed among the 100 researchers most cited in the scientific literature. He is president of The International Neuropeptide Society/Society for Biologically Active Peptides and was founding Editor-in-Chief of the international journal Peptides for 35 years.


Pennington Biomed. Res. Ctr., Baton Rouge

(Cardiovascular/Hematologic Agents)
Dimitri Mikhailidis (Biography
Dimitri Mikhailidis

Dimitri Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor, Univ. of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis.

He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,118 citations on the ISI index, Core Collection (H-factor 64).


Royal Free Hospital

Qing Yang (Biography
Qing Yang

Dr. Qing Yang has been a full professor of Biochemistry at the Dalian University of Technology (DUT, China) since 2007. Dr. Yang obtained her PhD degree in biochemical engineering at DUT in 2003. She did a postdoc at Howard Medical School in 2005-2006 and worked as a research fellow at the University of California, Berkeley in 2006-2008. In 2014, Dr. Yang was awarded “The National Science Fund for Distinguished Young Scholars”. The major interest of her lab is to discover novel targets for plant protection and disease treatment, especially enzymes involved in the synthesis and degradation of chitin, the structural polysaccharide of insect cuticles and fungi cell walls. Her lab has been the first to report the crystal structures of several important insect chitinolytic enzymes.


Dalian University of Technology

(HIV Agents)
Howard Gendelman (Biography
Howard Gendelman

Dr. Howard E. Gendelman is the Margaret R. Larson Professor of Internal Medicine and Infectious Diseases and Chairman of the Department of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center. He is credited in unraveling how functional alterations in brain immunity induce metabolic changes and ultimately lead to neural cell damage for a broad range of infectious and neurodegenerative disorders. These discoveries have led to novel therapeutics aimed at reversing neural maladies. He obtained a Bachelor’s degree in Natural Sciences and Russian Studies from Muhlenberg College and his M.D. from the Pennsylvania State University where he was the 1999 Distinguished Alumnus.


University of Nebraska Med. Ctr
Omaha, NE

Alexander V. Kabanov
University of North Carolina at Chapel Hill
Chapel Hill, NC

(Anti-hypertensive Agents)
Gregory Lip
City Hospital

(Computer Assisted Drug Design)
Rami Reddy (Biography
Rami Reddy

Dr. Reddy obtained a doctorate (Ph. D.) in Computational Chemistry from the Central University of Hyderabad, Hyderabad, India. Dr. Reddy is a founder of Rational Labs and is highly accomplished computational Chemist with a proven track record in drug discovery and CADD software development. Dr. Reddy has over 25 years of experience in drug discovery working in several Pharmaceutical and Biotech companies such as Agouron Pharmaceuticals (now Pfizer), Gensia Pharmaceuticals, Metabasis Therapeutics and Rational Labs. Dr. Reddy’s drug discovery efforts have resulted in one marketed drug for AIDS and several clinical compounds for cancer and diabetes. Dr. Reddy is an author of over 100 publications and patents.


RR Labs Inc
San Diego, CA

Editorial Board Members:

Vasilios G. Athyros
Aristotelian University, Medical School

Steven J. Brickner
University of New South Wales
Groton, CT

Stevan W. Djuric (Biography
Stevan W. Djuric

Dr. Djuric received a doctorate (PhD) in chemistry from the University of Leeds (UK) followed by a postdoctoral fellowship with Professor Philip D Magnus at the Ohio State University. He holds an Adjunct Professorship in the Department of Medicinal Chemistry at the University of Kansas. He is head of the global AbbVie Medicinal Chemistry Leadership team and is also responsible for the Discovery Chemistry and Technology organization within their Discovery organization He has over 180 scientific publications, presentations and patents. He has given over 30 invited lectures at universities and national meetings. He is a member of several Editorial Advisory Boards including the journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Current Pharmaceutical Design.


Abbott Laboratories
Abbott Park, IL

Nigel H. Greig (Biography
Nigel H. Greig

Nigel H. Greig (Ph.D. Pharmacology, University of London, England) heads the Drug Design & Development Section within the Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health. Located in Baltimore, MD, USA, his program combines cellular, molecular and in vivo pharmacology with medicinal chemistry to design and development novel experimental drugs against rate-limiting steps involved in the pathophysiology of diseases associated with aging, with an emphasis on the nervous system. Nigel, together with his exceptional collaborators and research group have successfully moved multiple experimental drugs from concept through preclinical studies and into human clinical trials.


National Institutes of Health
Baltimore, MD

Keith W. Kelley (Biography
Keith W. Kelley

Keith W. Kelley is a Professor Emeritus of Immunophysiology at the University of Illinois. Dr. Kelley earned his Ph.D. in 1976, a time when the immune system was considered only to protect against infectious diseases. He helped reshape that view by bringing physiology to immunology. It is now accepted that there is an active dialogue between the immune system and brain, and these discoveries are improving human and animal health. Professor Kelley has been honored with 10 university and national awards, published more than 250 peer-reviewed scientific papers as well as 70 book chapters, is well cited with an h-index of 68, been funded for 50 years as the Principal Investigator of NIH grants and served on four dozen NIH study sections. He is currently a Full Member of the Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section. Dr. Kelley is a Past-President and Secretary-Treasurer of the PsychoNeuroImmunology Research Society. He has been Editor-in-Chief of Brain, Behavior, and Immunity since 2003. The latest impact factor of the journal is 5.9, ranking it in the top 14% of all immunology journals and 11% of neuroscience journals.


University of Illinois

JoEllyn McMillan (Biography
JoEllyn McMillan

Dr. McMillan earned a Ph.D. in Toxicology from Texas A&M University, College Station, TX, USA. She held a post-doctoral fellowship at the National Center for Toxicological Research, Jefferson AR, USA, and a second post-doctoral fellowship in the Department of Pharmacology and Experimental Therapeutics, College of Medicine, at the Medical University of South Carolina, Charleston SC, USA. She remained at the Medical University of South Carolina as an Assistant Professor in the Pharmacology Department and then moved to the University of Nebraska Medical Center, Omaha, NE, USA, in 2007. She holds a joint appointment in the Department of Pharmacology and Experimental Neuroscience, College of Medicine, and the Department of Environmental, Agricultural and Occupational Health, College of Public Health. She has authored/coauthored over 70 scientific publications and book chapters.


University of Nebraska Medical Center
Omaha, NE

Ruth Nussinov (Biography
Ruth Nussinov

Ruth Nussinov graduated from Rutgers, was in the Weizmann Institute, the Chemistry Department at Berkeley and Biochemistry at Harvard. She joined the Medical School in Tel Aviv and accepted a concurrent position at the National Cancer Institute, Leidos. She has co-authored over 550 papers. She is the Editor-in-Chief in PLoS Computational Biology, and an Associate Editor and on the Editorial Boards of several journals. She is a frequent speaker in Domestic and International meetings, symposia and academic institutions, won several awards and elected fellow of several societies. Her National Cancer Institute website describes her science, and major contributions. https://ccr.cancer.gov/ruth-nussinov.


National Cancer Institute
Frederick, MD

Matteo Antonio Russo (Biography
Matteo Antonio Russo

Prof. Matteo A. Russo obtained his Medical Degree from Catholic University Medical School in Rome (Italy). He specialized in Oncology, General Pathology (from University of Rome Sapienza) and Cardiology (Catholic University Medical School). Soon after he got a track tenure at University of Rome Sapienza Medical School, first, as Associate Professor of Experimental Oncology and then as Full Professor of General Pathology. At present, he is the Head of Basic Research and Laboratories at San Raffaele Scientific Institute; he is also President of MEBIC (Medical and Experimental Bioimaging Center, a joint consortium between San Raffaele University and University of Rome Tor Vergata). He has published more than 150 scientific papers, being awarded by three international prizes for Basic Research. Prof. Russo is member of the editorial board of 6 peer-reviewed journals.


IRCCS Foundation Rome, Molecular and Cell Biology Laboratory

Claudiu T. Supuran (Biography
Claudiu T. Supuran

is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).


Universita degli Studi di Firenze

Bing Yan (Biography
Bing Yan

Bing Yan got his Ph.D. from Chemistry Department of Columbia University in 1990. He then carried out postdoctoral research at Physiology Department of University of Cambridge, U.K. and Department of Microbiology and Molecular Genetics at University of Texas Medical School in Houston from 1990 to 1993. From 1993 to 2005, he carried out drug discovery research at Novartis, Discovery Partners International, and Bristol-Myers Squibb. He was a Full Professor and Director of High-Throughput Analytical Chemistry Center at Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital in Memphis, Tennessee from 2007 to 2012 and Cheung Kong Scholar Professor at Shandong University, Jinan, China since 2005. He served as Associate Editor for “Journal of Combinatorial Chemistry (name now changed to ACS Combinatorial Sciences)” published by American Chemical Society from 2009 to 2011. He is now serving as Associate Editor for both “Ecotoxicology and Environmental Safety” and Elsevier’s new journal “NanoImpact”. He is also editor of book series “Critical Reviews in Combinatorial Chemistry” published by Francis & Taylor Group. He has published 11 books and more than 210 peer-reviewed papers. He is interested in drug discovery, nanomedicine, and modulation of biological activities of nanoparticles using systematic approaches.


Shandong University

Scott A. Biller
Novartis Institutes for BioMedical Research
Cambridge, MA

Allan Butterfield (Biography
Allan Butterfield

Dr. Butterfield earned his Ph.D. at Duke University in physical chemistry followed by a NIH Postdoctoral Fellowship in neuroscience at the Duke University School of Medicine. In 1975, Dr. Butterfield joined the faculty of Chemistry at the University of Kentucky and rose to Full Professor in 1983. Prof. Butterfield is the UK Alumni Association Endowed Professor of Biological Chemistry and Associate Vice President for Research at UK. He is a faculty member of the Sanders-Brown Center on Aging. Prof. Butterfield has over 620 refereed scientific publications, mostly on oxidative stress in brain in subjects with Alzheimer disease and its earlier stages. Dr. Butterfield pioneered the field of redox proteomics, by which oxidatively modified proteins can be identified. He has edited five books, and published over 150 abstracts, most of which were refereed. His work has been continuously funded at the University of Kentucky by federal grants from NIH, NSF, and DoD as well as foundation grants. He has trained over 60 Ph.D and M.S. students and over 25 postdoctoral scholars and visiting scientists. He has received a Presidential Award for Excellence in Science Mentoring from President Clinton at the White House, and an Honorary Doctor of Science Degree from his undergraduate alma mater, the University of Maine. Prof. Butterfield was named the 39th most cited and influential researcher on Alzheimer disease in the world as cited in the Journal of Alzheimers Disease. He is on the editorial boards of 14 journals, including Current Pharmaceutical Design.


University of Kentucky
Lexington, KY

Roland E. Dolle
Pharmacopeia, Inc
Princeton, NJ

James M. Hamby
Parke-Davis, Pharm. Res
Ann Arbor, MI

Marlys Koschinsky
Queen's University

John E. Morley (Biography
John E. Morley

John E. Morley, MB, BCh, is the Dammert Professor of Gerontology, Director, Division of Geriatric Medicine and Director of the Division of Endocrinology at Saint Louis University School of Medicine. He serves as Medical Director for two nursing homes. Dr. Morley earned a medical degree at the University of Witwatersrand in Johannesburg, South Africa. He is board certified in Internal Medicine, Endocrinology and Geriatric Medicine. He has edited over 20 books, and published more than 1300 manuscripts. He has an h-factor of 107. He serves as Editor of Journal of the American Medical Directors Association, impact factor 6.61.


St. Louis University Health Sciences Center
St. Louis, MO

Waldemar Priebe (Biography
Waldemar Priebe

Dr. Priebe obtained a Master of Science in Organic Chemistry degree from the University of Warsaw in Poland and a doctorate (Ph.D.) in Organic and Medical Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences in Poland. He is a Professor of Medicinal Chemistry at The University of Texas M. D. Anderson Cancer Center in Houston and also holds the title of Professor of Chemistry in the Republic of Poland. Prof. Priebe is noted for his successful development of new therapeutic entities for the treatment of cancer. Five of his drugs entered clinical trials and several others are in different stages of preclinical development. He has published more than 200 scientific publications and his work has led to over 50 patents.


University of Texas
Houston, TX

Andrew V. Schally (Biography
Andrew V. Schally

Andrew V. Schally, Ph.D., M.D.h.c., received his training in England, Canada, Sweden, and USA. In the years 1954-1977 he worked in the field of neuroendocrinology. Dr. Schally’s group isolated and elucidated the structure of hypothalamic LHRH. Dr. Schally was awarded the Nobel Prize in Medicine in 1977 for his work on hypothalamic peptides. Dr. Schally switched then to cancer research. He is a world leader in research on hormone-related cancers and treatment of prostate and other cancers. Various classes of anticancer peptides were developed in his laboratory. Dr. Schally is the Professor of Pathology and Medicine at the University of Miami School of Medicine, Chief of the Endocrine, Polypeptide Cancer Institute at the VA Medical Center, Miami, Florida and Distinguished Medical Research Scientist. He has more than 2500 publications to his credit.


(Nobel Laureate)
New Orleans, LA

Nese Tuncel (Biography
Nese Tuncel

Dr. Neşe Tunçel received her BS in Pharmacy in 1970 and her PhD in Medical Physiology in 1982 from Ankara University, Turkey. She has been served as a Professor in the Department of Physiology and Neurophysiology, Faculty of Medicine, Eskis􏰁ehir Osmangazi University, and she was retired in April 2016. She has 95 scientific publications. She also serves as a member of the Editorial boards of several academic journals including Current Pharmaceutical Design, Medicinal Chemistry, Recent Patents on Anti-Cancer Drug Discovery, The Open Cancer Journal, Biomedical Review and Adipobiology, Current Clinical pharmacology. She has also served in the Editorial Advisory Board of Peptides in the period 1998-2010 and, Immunology, Endocrine and Metabolic Agents for three years.


Osmangazi University

Xiaojun Yao (Biography
Xiaojun Yao

Xiaojun Yao received his Ph.D. degree in chemoinformatics and theoretical chemistry from University Paris 7-Denis Diderot, Paris, France, in 2004. He works as a Professor of chemoinformatics and analytical chemistry in College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China. His current research interests include computer-aided molecular design, bioinformatics, and computational biology.


Lanzhou University

Yuri V. Bobryshev (Biography
Yuri V. Bobryshev

Prof. Bobryshev obtained a doctorate (Dr.Sc.) from the Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences. Currently Dr Bobryshev is a Senior Research Associate of the Faculty of Medicine, University of New South Wales, Sydney, Australia and Adjunct Associate Professor of the School of Medicine, University of Western Sydney, Australia. Dr Bobryshev is a Fellow of Faculty of Science of the Royal College of Pathologists of Australasia (RCPA). Dr Bobryshev has published more than 300 scientific publications.


University of New South Wales

Elisabeth G.E. De Vries
Univ. of Groningen

Catherine L. Farrell
Amgen, Inc., Thousand Oaks

Tingjun Hou (Biography
Tingjun Hou

Dr. Hou obtained a doctorate (Ph.D.) in Computational Chemistry from Peking University in 2002 and is currently the professor for College of Pharmaceutical Sciences at Zhejiang University in Hangzhou. His research focuses on development of new methods for computer-aided drug design (CADD) and design of potential lead compounds for important drug targets. He has published more than 260 peer reviewed papers in international prestigious SCI-cited journals, 4 book chapters and 1 multimedia courseware.


Soochow University
Suzhou, Jiangsu

Kit S. Lam
UC Davis Cancer Center
Sacramento, CA

John H. Musser
Alameda, CA

Manfredi Rizzo (Biography
Manfredi Rizzo

Prof. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy as well as Associate Professor of Internal Medicine at the School of Medicine, University of South Carolina, USA. Prof. Rizzo sits on the editorial board of 9 international journals with Impact Factor. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-lowering and anti‐diabetic agents) and basic research (focus on novel cardiovascular risk factors), with 200+ scientific publications with Impact Factor (total Impact Factor: >700. H‐Index: 42).


University of Palermo

Claudio Soto (Biography
Claudio Soto

Dr Claudio Soto is Professor of Neurology and Director of the Mitchell Center for Alzheimer’s disease and related Brain Disorders at the University of Texas in Houston. He received his PhD from the University of Chile in 1993. His research focuses in understanding the molecular basis of neurodegenerative diseases associated to the misfolding and aggregation of proteins, particularly Alzheimer’s and prion disorders. He has published more than 160 peer review articles, many of which have been published in prestigious scientific journals (including Cell, Nature, Science, New England Journal of Medicine, Nature medicine, Lancet, etc). Dr Soto's publications have been cited more than 12,000 times (H index 59). He has been awarded many grants from NIH, and private foundations for a total funding of over 30 million dollars, and has been invited speaker in more than 160 scientific meetings worldwide.


University of Texas Medical Branch
Galveston, TX

Antonino Tuttolomondo (Biography
Antonino Tuttolomondo

Prof. Tuttolomondo, obtained two post graduate degree ( Internal Medicine and Neurology) and a doctorate (Ph.D.) in Genetic and Pathophysiology of Cardiovascular Damage in Metabolic Diseases from the University of Palermo ( Italy)

Currently Prof. Tuttolomondo is Associate Professor in Internal Medicine in University of Palermo ( Italy). He has published more than 130 scientific publications on international, ISI and medium-high impact factor journals and inherent in the pathophysiology and epidemiology of ischemic stroke, heart failure, diabetic foot and Anderson-Fabry Disease .


Università degli Studi di Palermo

Executive Guest Editor(s):

Umberto Aguglia / Ettore Beghi

Issue Title: Novel Perspectives in the Treatment of Epilepsy

Karel Allegaert / John Van Den Anker
(Belgium / USA)

Issue Title: Neonatal Clinical Pharmacology

Marco Alves

Issue Title: The Aging Male Physiology, Pathophysiology and Therapeutic Perspectives

Maciej Banach / Maria-Corina Serban / Amirhossein Sahebkar
(Poland / Romania / Iran)

Issue Title: Natural Products in Health and Disease

Lillian Barros / Isabel Ferreira

Issue Title: Phytochemicals and their Effects on Human Health

Loredana De Bartolo / Simona Salerno

Issue Title: Nanotechnology and Biomaterials for Cell and Drug Therapy

Stefanos Bonovas / Georgios Nikolopoulos
(Italy / Greece)

Issue Title: HIV and Antiretroviral Drugs: Current Status and New Challenges

Li Yue-Chun

Issue Title: Inflammation and Heart Diseases

Jose Correa

Issue Title: Nanoparticles-dendrimers for Pharmaceutical uses

João Eurico Cortez Cabral da Fonseca / Joao Goncalves

Issue Title: The Explosion of Biosimilars in Immune Mediated Chronic Inflammatory Diseases

Martin Federico Desimone / Gorka Orive
(Argentina / Spain)

Issue Title: Recent Advances and Innovative Strategies Applied in the Development of Biomaterials

Dominico Di Raimondo

Issue Title: Management of Elevated Heart Rate in Essential Hypertension: Pathophysiological Insights and Therapeutic Approach

Claudia Nunes dos Santos / Regina Menezes

Issue Title: Polyphenols as new Leads in Drug Discovery: Biological Activity and Mechanisms

Marcos André Vannier dos Santos

Issue Title: Parasite Polyamines as Pharmaceutical Targets

Ahmed Elzoghby

Issue Title: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy

Ana Raquel Esteves

Issue Title: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

Davide Grassi

Issue Title: Nutraceuticals in Human Health (Polyphenols as Nutraceuticals)

Andrzej Grzybowski

Issue Title: Hot topics in Ocular Pharmacology

Pierre Guertin

Issue Title: Spinal Locomotor Systems

Ignacio Zapardiel Gutiérrez

Issue Title: Current Drugs and Products used for Sentinel Node Mapping in Gynaecological Cancers

Shilei Hao

Issue Title: Review Intracerebral Haemorrhage (ICH): Mechanisms of Injury and Therapeutic Targets

Jiman He

Issue Title: Common Therapeutic Targets for both Insulin Resistance and Cancer

Syed Vahid Hosseini

Issue Title: Emerging Technologies in Drug Delivery and Screening

Zunnan Huang

Issue Title: Recent Advances in the Field of Kinases and Kinase Inhibitors

Mohammad Amjad Kamal / Nigel H. Greig
(Australia / USA)

Issue Title: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases

Theodora Katsila / George Patrinos

Issue Title: Pharmacometabolomics in Precision Medicine

Takeshi Kurose

Issue Title: Advances in Diabetes related Membrane Receptor Signaling

Julia Kzhyshkowska / Ron N. Apte / Mariano Bizzarri / Nadezda Cherdyntseva
(Germany / Israel / Italy / Russia)

Issue Title: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy

Binbin Li

Issue Title: New Strategies for the Prevention and Treatment of Bone Loss

Aurelio Leone / Luigi Landini

Issue Title: Modifying Cardiovascular Risk Factors: Acquired Topics and Emerging Concepts

Dejia Li

Issue Title: Towards miRNA-Based Therapeutics for Lung Cancer

Jesus Fernandez Lucas

Issue Title: New Trend in Enzymatic Synthesis of Nucleic Acid Derivatives

Soraya Vallés Marti

Issue Title: Signaling Mechanisms of Brain Inflammation

Ikuko Miyazaki

Issue Title: Astrocyte-targeted Therapeutic Strategies for Neurological Disorders

Joseph Fomusi Ndisang

Issue Title: The different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments

Hisham Al-Obaidi

Issue Title: Applications of Particulate Carriers in Drug Delivery: Challenges and Future Perspectives

Alexander Orekhov

Issue Title: Convenient, Traditional and Alternative Therapies for Cardiovascular Disorders

Laurent Peyrin-Biroulet / Silvio Danese
(France / Italy)

Issue Title: Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease

Emma Piacentini / Lidietta Giorno

Issue Title: Membranes Technologies for Pharmaceutical Applications

Sandra Reznik

Issue Title: Novel Pharmacotherapeutic Targets and Emerging Approaches to Prevent Preterm Birth

Luis Javier Cruz Ricondo

Issue Title: Targeting Nanomedicine to the Brain: Diagnostics, Prevention and Treatment

Seiji Shioda / Illana Gozes
(Japan / Israel)

Issue Title: Neuropeptides from Bench to Bedside

Alberto Signore

Issue Title: The future of Nuclear Medicine Imaging of Inflammation and Infections

Predrag Sikiric

Issue Title: Stress and GI tract: Physiology, Pathophysiology, Pathology and Pharmacology

Pichini Simona / Francesco P. Busardo

Issue Title: Advances and Future Developments in Forensic Toxicology: From Standard Practices to new Psychoactive Substances

Eduardo Sobarzo-Sánchez

Issue Title: An Approach to the Theoretical and Experimental Design of Fused Compounds in the Treatment of Mental and Motor Dysfunctions

Karmen Stankov

Issue Title: Discovery and Validation of Drug Targets Through Human Genetics and Epigenetics

Oriana Tabarrini / Serena Massari

Issue Title: Acting on Tat-mediated Transcription to Achieve a Long Term Control of HIV-1 Latency

Marios Themistocleous / Kostas Margetis / George Stranjalis
(Greece / USA / Greece)

Issue Title: Antiepileptic Drugs in Neurosurgical Practice

Dimitris Tousoulis / Evangelos Oikonomou

Issue Title: Statins Beyond Lipid Lowering Effects

Ravichandra Vemuri

Issue Title: Novel Interventional Targets for Gastrointestinal and Metabolic disorders

Dimitrios Vrachatis / Manolis Vavuranakis / Dimitrios Tousoulis

Issue Title: Antiplatelet and Anticoagulation Treatment in Special Populations

Junchao Wei / Jianxun Ding

Issue Title: Advanced Antibacterial Materials & Interfaces

Robert Weissert

Issue Title: Multiple Sclerosis – Therapeutics and Novel Approaches for Therapy

JiuChang Zhong / Gavin Oudit
(China / Canada)

Issue Title: Targeting the Apelin Pathway as a Novel Therapeutic Approach for Cardiovascular Disease

Lixin Zhu

Issue Title: Modernizations, Applications and Efficacies of Herbal Medicine

RNA Therapeutics

Related Journals

Related eBooks

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science